Developing new antimicrobial agents and cancer treatments
Bioorganic Approaches Toward Novel Antimicrobial Agents and Chemotherapeutics
This study is working on new tools to help us understand and treat tough health problems like bacterial infections and cancer, so that patients can have better treatment options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10841864 on NIH RePORTER |
What this research studies
This research focuses on creating innovative molecular probes that can help us better understand and treat human diseases, particularly bacterial infections and cancers. By combining organic chemistry with biological applications, the team aims to tackle complex health issues through the development of new chemical reactions and synthesis strategies. Patients may benefit from advancements in treatments that target resistant bacterial strains and malignant tumors, as the research seeks to provide solutions to pressing medical challenges.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections that are resistant to current treatments or patients diagnosed with certain types of cancers.
Not a fit: Patients with non-bacterial infections or those whose cancers are not addressed by the specific therapies being developed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective antimicrobial agents and cancer therapies.
How similar studies have performed: Other research has shown promise in developing novel antimicrobial agents and cancer treatments using similar approaches, indicating a potential for success in this area.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Townsend, Steven D. — Vanderbilt University
- Study coordinator: Townsend, Steven D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.